Clinical Trial Update: Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia [Phase 3]

View source ↗

Summary

Clinical trial update on convalescent plasma for severe COVID-19 pneumonia, completed Phase 3 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Convalescent Plasma (convalescent plasma)

Snippet

Sponsor: Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno | Conditions: Covid19 Pneumonia | Phase 3 | Status: COMPLETED